The aim of this article is to give a non-technical overview of AI and its medical applications, with particular emphasis on large language models.

These questions are based on the Focus articles in this issue.

A case presentation of a man, aged 55 years, presenting with a 3-year history of gradually progressive, asymptomatic hyperpigmented patches on his upper back.

The aim of this article is to provide an overview of evidence-based non-pharmacological strategies for ADHD that may assist patients in general practice.

This paper describes the referral pathways, wait times and medication outcomes in the first 207 children diagnosed with ADHD in 2023–26 by four GPs trained in ADHD management.

This article provides expert and evidence-based recommendations to guide screening, management and harm reduction relevant to methamphetamine-associated cardiovascular conditions.

This article aims to provide a practical guide for GPs in Australia seeking to initiate stimulant or non-stimulant ADHD medication.

This article aims to support GPs in engaging with patients who use anabolic androgenic steroids and other PIEDs and outline practical harm-reduction strategies.

The aim of this paper is to review current evidence, international recommendations and future directions around testing and management of elevated lipoprotein(a).

Readers express their opinions on published articles and topics of interest.

Exploring our lives, as GPs, outside the clinic.

This study sought to understand the prevalence and characteristics of health-related notifications to inform efforts to support GP wellbeing while protecting patient safety.

The aim of this paper is to describe a practical model that identifies opportunities for everyday tasks to be adapted to better support GPs’ wellbeing.

The aim of this paper is to explore GP views on weight stigma in maternity care to inform recommendations for non- stigmatising care.

This article summarises the medicolegal issues that might affect GPs when initiating, continuing and monitoring ADHD medications in children and/or adults.